| Jerry Paul Gilless, MD | |
|
1265 Union Ave, Memphis, TN 38104-3415 | |
| (901) 337-0027 | |
| Not Available |
| Full Name | Jerry Paul Gilless |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 18 Years |
| Location | 1265 Union Ave, Memphis, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639372535 | NPI | - | NPPES |
| 205988001 | Medicaid | AR | |
| 1526563 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 47405 (Tennessee) | Secondary |
| 207R00000X | Internal Medicine | 47405 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Healthcare Memphis Hospitals | Memphis, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Methodist Inpatient Physicians Llc | 1254241235 | 112 |
News Archive
About 20 percent of colorectal cancer patients have cancers that have spread (metastasized) beyond the colon at the time of their diagnosis. The liver is the most common site for these metastases. The approach to treating primary tumors within the colon and metastatic tumors in the liver continues to evolve; however, it typically involves chemotherapy plus surgical removal (resection) of both types of tumors. However, experts continue to debate whether surgical resection of primary tumors and metastatic tumors should be performed at the same time (synchronously) or in separate operations (sequentially).
An agreement was reached today between Ensocare and New Jersey-based iMPak Health to include iMPak's innovative medication management system, Kraken, as part of the Ensocare sales portfolio. Ensocare will serve as an authorized re-seller for the Kraken system, which may be sold alone or, in the future, as an integrated feature inside of Ensocare's Sync and Connect software engines.
Your house number could be the key to the safe relaxation of COVID-19-related restrictions if government follow a new exit strategy proposal published today in the British Medical Journal.
Schering-Plough today reported that the U.S. Food and Drug Administration (FDA) has granted approval for Temodar (temozolomide) Capsules for use in combination with radiotherapy for the treatment of adult patients with newly diagnosed glioblastoma multiforme (GBM), a form of malignant brain cancer.
› Verified 7 days ago
| Entity Name | Methodist Inpatient Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609850692 PECOS PAC ID: 1254241235 Enrollment ID: O20050815000700 |
News Archive
About 20 percent of colorectal cancer patients have cancers that have spread (metastasized) beyond the colon at the time of their diagnosis. The liver is the most common site for these metastases. The approach to treating primary tumors within the colon and metastatic tumors in the liver continues to evolve; however, it typically involves chemotherapy plus surgical removal (resection) of both types of tumors. However, experts continue to debate whether surgical resection of primary tumors and metastatic tumors should be performed at the same time (synchronously) or in separate operations (sequentially).
An agreement was reached today between Ensocare and New Jersey-based iMPak Health to include iMPak's innovative medication management system, Kraken, as part of the Ensocare sales portfolio. Ensocare will serve as an authorized re-seller for the Kraken system, which may be sold alone or, in the future, as an integrated feature inside of Ensocare's Sync and Connect software engines.
Your house number could be the key to the safe relaxation of COVID-19-related restrictions if government follow a new exit strategy proposal published today in the British Medical Journal.
Schering-Plough today reported that the U.S. Food and Drug Administration (FDA) has granted approval for Temodar (temozolomide) Capsules for use in combination with radiotherapy for the treatment of adult patients with newly diagnosed glioblastoma multiforme (GBM), a form of malignant brain cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jerry Paul Gilless, MD 1211 Union Ave Ste 330, Memphis, TN 38104-6655 Ph: () - | Jerry Paul Gilless, MD 1265 Union Ave, Memphis, TN 38104-3415 Ph: (901) 337-0027 |
News Archive
About 20 percent of colorectal cancer patients have cancers that have spread (metastasized) beyond the colon at the time of their diagnosis. The liver is the most common site for these metastases. The approach to treating primary tumors within the colon and metastatic tumors in the liver continues to evolve; however, it typically involves chemotherapy plus surgical removal (resection) of both types of tumors. However, experts continue to debate whether surgical resection of primary tumors and metastatic tumors should be performed at the same time (synchronously) or in separate operations (sequentially).
An agreement was reached today between Ensocare and New Jersey-based iMPak Health to include iMPak's innovative medication management system, Kraken, as part of the Ensocare sales portfolio. Ensocare will serve as an authorized re-seller for the Kraken system, which may be sold alone or, in the future, as an integrated feature inside of Ensocare's Sync and Connect software engines.
Your house number could be the key to the safe relaxation of COVID-19-related restrictions if government follow a new exit strategy proposal published today in the British Medical Journal.
Schering-Plough today reported that the U.S. Food and Drug Administration (FDA) has granted approval for Temodar (temozolomide) Capsules for use in combination with radiotherapy for the treatment of adult patients with newly diagnosed glioblastoma multiforme (GBM), a form of malignant brain cancer.
› Verified 7 days ago
Khawaja Muhammad Muddassir, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1325 Eastmoreland Ave, Suite 370, Memphis, TN 38104 Phone: 901-758-7888 Fax: 901-387-5153 | |
Allison Montague, Internal Medicine Medicare: Medicare Enrolled Practice Location: 1955 S 3rd St, Memphis, TN 38109 Phone: 901-515-5800 | |
Dr. Marcia Bradford, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 360 E Eh Crump Blvd, Memphis, TN 38126 Phone: 901-261-2000 Fax: 901-946-9262 | |
Dr. Aleksandar Jankov, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6029 Walnut Grove Rd, Suite 301, Memphis, TN 38120 Phone: 901-747-9081 Fax: 901-747-9087 | |
Manoj K Jain, MD, MPH Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6029 Walnut Grove Rd Ste 209, Memphis, TN 38120 Phone: 901-681-0778 Fax: 901-821-9987 | |
Dr. Karl Weber, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 880 Madison Ave, Memphis, TN 38103 Phone: 901-545-6969 Fax: 901-545-4739 | |
Dr. Pedro Velasquez, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1068 Cresthaven Rd Ste 300, Memphis, TN 38119 Phone: 901-683-0024 Fax: 901-683-0086 |